FreeStyle Libre 3 Plus vs Libre 3: Which One is Phase Out?

Among the most reliable continuous glucose monitors in the USA are the Freestyle Libre sensors. And the Freestyle Libre 3 sensors have been one of the most reliable in this series before 2025, but in 2026, the old models of Libre 2 and 3 have been phased out completely by Abbott. What steps do you have to take in this phase-out update? Simply pick Libre 2 plus and Libre 3 plus and manage your diabetes unstoppable. Here we’ll have a look at what Libre 3 had, since it has now been discontinued, and what Libre 3 Plus has. Let’s dive into Libre 3 Plus vs Libre 3.

Please note that the unit of measuring the accuracy of CGM sensors is called MARD (mean absolute relative difference); the lower the number, the higher the accuracy. Typically, CGMs with an MARD value of ≤10 are considered to have good accuracy.

The FreeStyle Libre 3 (phase out) and Libre 3 Plus are Abbott’s latest continuous glucose monitoring systems, designed for simplicity and discretion. Both share a similar foundation but differ in key areas that matter most to users. Here, we discussed it in a chunk for your understanding.

Wear Time Difference

• Phase-out FreeStyle Libre 3: These sensors offer up to 14 days of life before needing replacement. It means you need 2 sensors for 28 days.
• FreeStyle Libre 3 Plus: These sensors give you 15 days of wear time. Well, you need 2 sensors to complete your month. It provides you with an extra day of managing your glucose level and slightly reduces the sensor placement frequency throughout the month.

Mard Value Differences

• FreeStyle Libre 3: It has an overall MARD of 7.9%
• FreeStyle Libre 3 Plus: This sensor has an overall MARD of 8.1% and 8.2%.

Age Range for Usage Difference

• Phase-out Freestyle Libre 3: FDA-approved for users aged 4 and above, it’s easy to use but might limit younger patient whose age is less than 4.
• Freestyle  Libre 3 Plus: FDA now approved for use in children as young as two years old, it offers a more inclusive solution for families managing diabetes in younger children.

Integration with Automated Insulin Delivery Systems

• Phase-out Libre 3: The Libre 3 offers limited AID compatibility, primarily supporting integration with select third-party systems. While it can connect to certain insulin pumps, its closed-loop capabilities are more restricted compared to its successor, making it better suited for users who primarily rely on manual insulin adjustments with CGM guidance.
• FreeStyle Libre 3 Plus: The Libre 3 Plus takes AID integration further, with confirmed compatibility with the Beta Bionics iLet Bionic Pancreas and expanding support across other pump platforms as of 2026. Its every-minute glucose streaming makes it particularly capable for closed-loop systems, allowing real-time automatic insulin adjustments that reduce manual dosing burden and improve overall glucose control for insulin-dependent users.

Features of Accuracy and Performance

• FreeStyle Libre 3 – delivers strong accuracy with a MARD of 7.9%, providing reliable real-time glucose readings with minimal lag. It gives users a clear and consistent picture of their glucose trends throughout the day, making it a dependable choice for everyday diabetes management.
• FreeStyle Libre 3 Plus – Improves on this with a MARD of 8.2%, offering slightly sharper accuracy and the same minimal lag in real-time readings. For users on AID systems, this enhanced accuracy becomes even more valuable.

Sensor Compatibility with App and Reader

Both the Libre 3 and Libre 3 Plus are compatible with the FreeStyle Libre 3 app and the Libre 3 reader, making it seamless for existing Libre 3 users to upgrade to the Plus without switching devices or platforms.

App

The FreeStyle Libre 3 app enables continuous glucose monitoring directly on a smartphone, giving users real-time glucose levels, trend arrows, and customizable alerts — all from their mobile device.

Reader

For those who prefer a dedicated device, the Libre 3 reader offers the same core functionality without relying on a smartphone, providing a practical alternative for users who want a separate, focused device for glucose monitoring.

As far as insurance coverage is concerned, please note that according to Abbott, the Freestyle Libre 3 Plus sensors have the same Medicare coverage as the Freestyle Libre 3 sensors. However, existing Libre 3 users will require a new prescription to obtain the Freestyle Libre 3 Plus sensors, and our experts at CGM Monitors are always available to assist you with this process.

Many insurance program is meant for patients with type 1, type 2, and gestational diabetes. Rest, it varies depending on the type of insurance you have, e.g., Medicare/Medicaid or any other private insurance. Veterans and TRICARE coverage may be checked here.

Common Shared Features

• Size: Both sensors are physically identical and rank among the smallest CGMs available on the diabetes market.
• Functionality: Both provide real-time, continuous glucose streaming to a smartphone app every minute.
• Installation: Both follow a similar, simple, and straightforward application process.

Factors to Consider When Choosing Libre Sensor

• Sensor Wear Duration: Libre 3 Plus lasts one day longer (15 days vs 14 days). It’s a small improvement, but for people who prefer fewer sensor changes, this is a plus.
• Pump Integration: Libre 3 Plus supports automated insulin delivery (AID) systems, which means it can connect with compatible insulin pumps for closed-loop control. If you plan to switch to an insulin pump in the future, Plus is the smarter choice.
• Accuracy and Safety: Libre 3 Plus follows more rigorous performance standards, offering improved accuracy in critical glucose ranges—particularly for hypoglycemia or hyperglycemia alerts.
• Age Suitability: If the CGM is for a child under 4 years, Libre 3 Plus is the only suitable option since it’s approved for ages as young as 2.
• Product Longevity: Abbott is gradually transitioning from the Libre 3 to the Libre 3 Plus line. Choosing Libre 3 Plus ensures better long-term support, app updates, and future device compatibility.
• User Feedback: Most users find Libre 3 plus reliable and easy to use especially if they get a monthly subscription. Moreover, some early Libre 3 Plus users have mentioned slightly more insertion discomfort or occasional false alarms, but these experiences vary and often improve with newer batches.
• Cost and Availability: Libre 3 Plus is currently more affordable or easier to find in regions, but Libre 3 has been phased out. So Libre 3 Plus has become the standard replacement.

Which One Should You Choose?

As we know, Libre 2 and 3 have been permanently phased out in late 2025. If you want a future-ready CGM with longer wear time, improved accuracy, and compatibility with upcoming insulin pump systems — Libre 3 Plus is the better investment.

Conclusion

The Libre 3 and Libre 3 Plus both deliver exceptional CGM experiences but serve different needs. The Libre 3 is ideal for reliable, straightforward daily monitoring, while the Libre 3 Plus offers improved accuracy, longer wear, and growing AID compatibility, which makes this CGM sensor a stronger choice for those seeking a more automated, connected approach to diabetes management in 2026.
Both sensors share the same commitment to simplicity and discretion, making either a capable companion for daily glucose management. The best choice ultimately comes down to your lifestyle and how much connectivity and automation you need.

Frequently Asked Questions

Disclaimer: This blog is for informational purposes only and does not constitute medical, legal, or professional advice. While we strive for accuracy, errors or omissions may occur.
Some images in this blog may be AI-generated or for illustrative purposes only. Device images belong to their respective manufacturers and are used here for reference. Actual products may vary.